Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003655:Decerebrate State; D004285:Dogs; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D005260:Female; D006830:Hydralazine / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D006973:Hypertension / Q000188:drug therapy / Q000235:genetics; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D011724:Pyridazines / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D013116:Spinal Cord / Q000502:physiology; D013997:Time Factors
D004983:Ethanolamines; D006834:Hydrazines; D011724:Pyridazines; D006830:Hydralazine